Glaucoma is a serious eye disease that has the potential to blind. The best defenses are early eye exams designed to detect glaucoma early and slow its progression.
We use a non-invasive imaging test called optical coherence tomography (OCT) to detect the earliest retinal changes for patients with macular degeneration and nerve damage caused by glaucoma. With our high-definition Cirrus HD-OCT, the most advanced retinal and optic nerve imaging device available, we can detect these diseases years before traditional tests would discover them.
For retinal disorders, the Cirrus HD-OCT technology uses light waves to take cross-section pictures of your retinas. With them, our optometrists see each of the retina’s distinctive layers and measure their thicknesses. OCT also allows us to see changes in the retinal structure that might point to a range of disorders, and to refine treatments for a variety of retinal diseases.